CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-18 | ARMISTICE CAPITAL, LLC Director | Purchase | +20,000 | $2.78 | $56K | 39,300,000 |
| 2021-08-16 | ARMISTICE CAPITAL, LLC Director | Purchase | +30,000 | $2.75 | $83K | 39,280,000 |
| 2021-08-06 | ARMISTICE CAPITAL, LLC Director | Purchase | +25,000 | $2.83 | $71K | 39,250,000 |
| 2021-08-05 | ARMISTICE CAPITAL, LLC Director | Purchase | +25,000 | $2.77 | $69K | 39,225,000 |
| 2021-08-04 | ARMISTICE CAPITAL, LLC Director | Purchase | +100,000 | $2.69 | $269K | 39,200,000 |
| 2021-07-01 | COLA MICHAEL F Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +51,740 | 51,740 | ||
| 2021-06-30 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +3,465 | 3,465 | ||
| 2021-06-30 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +6,353 | 6,353 | ||
| 2021-06-30 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +4,620 | 4,620 | ||
| 2021-06-30 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +3,142 | 3,142 | ||
| 2021-06-30 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +3,985 | 3,985 | ||
| 2021-06-15 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-15 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-15 | BARER SOL J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-15 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-15 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-15 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-10 | NEIL GARRY ARTHUR Chief Scientific Officer | Purchase | +3,692 | $2.28 | $8K | 81,372 |
| 2021-06-10 | Greenway Schond L. CFO | Purchase | +652 | $2.68 | $2K | 1,652 |
| 2021-06-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +7,493 | $2.28 | $17K | 35,673 |
Page 17 of 25 · 500 trades